Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2021 Filed Jan 13, 2022 21:40 UTC Amendment |
Doyle AnthonyChief Financial Officer
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-001456 · form4a.xml · nonDerivative · entry 1 Doyle Anthony · CIK 0001808688 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,719 F1 · shares: The number of restricted stock units awarded to the reporting person on December 14, 2021 was overstated in the original Form 4 due to an administrative error. This amendment corrects the error and reflects the corrected amount of restricted stock units awarded to the reporting person on such date. Read SEC document |
| December 14, 2021 Filed Jan 13, 2022 21:38 UTC Amendment |
Gayer Charles KChief Commercial Officer
|
GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-001454 · form4a.xml · nonDerivative · entry 1 Gayer Charles K · CIK 0001800110 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,556 F1 · shares: The number of restricted stock units awarded to the reporting person on December 14, 2021 was overstated in the original Form 4 due to an administrative error. This amendment corrects the error and reflects the corrected amount of restricted stock units awarded to the reporting person on such date. Read SEC document |
| December 14, 2021 Filed Jan 13, 2022 21:36 UTC Amendment |
Barnes Alane PChief Legal Officer
|
GrantCommon Stock | 55,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-001452 · form4a.xml · nonDerivative · entry 1 Barnes Alane P · CIK 0001584348 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,969 F1 · shares: The number of restricted stock units awarded to the reporting person on December 14, 2021 was overstated in the original Form 4 due to an administrative error. This amendment corrects the error and reflects the corrected amount of restricted stock units awarded to the reporting person on such date. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:38 UTC |
Babu Yarlagadda SChief Discovery Officer
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 62,000 | $0.00 Strike: $4.73 | $0.00 |
DisclosureSEC source: 0001127602-21-030610 · form4.xml · derivative · entry 3 Babu Yarlagadda S · CIK 0001452635 · Chief Discovery Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,000 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:38 UTC |
Babu Yarlagadda SChief Discovery Officer
|
SaleCommon Stock | 30,100 | $12.20 | $367,220.00 |
DisclosureSEC source: 0001127602-21-030610 · form4.xml · nonDerivative · entry 2 Babu Yarlagadda S · CIK 0001452635 · Chief Discovery Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,056 F1 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $12.18 to $12.22. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:38 UTC |
Babu Yarlagadda SChief Discovery Officer
|
Exercise / conversionCommon Stock | 62,000 | $4.73 | $293,260.00 |
DisclosureSEC source: 0001127602-21-030610 · form4.xml · nonDerivative · entry 1 Babu Yarlagadda S · CIK 0001452635 · Chief Discovery Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 21:13 UTC |
LEVIN ALAN GDirector
|
GrantCommon Stock | 829 | $12.06 | $9,997.74 |
DisclosureSEC source: 0001127602-21-030059 · form4.xml · nonDerivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,457 F1 · security: Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 21:15 UTC |
ASELAGE STEVEDirector
|
GrantCommon Stock | 414 | $12.06 | $4,992.84 |
DisclosureSEC source: 0001127602-21-030063 · form4.xml · nonDerivative · entry 1 ASELAGE STEVE · CIK 0001221599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,858 F1 · security: Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $10,000. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 21:10 UTC |
HEGGIE THERESADirector
|
GrantCommon Stock | 829 | $12.06 | $9,997.74 |
DisclosureSEC source: 0001127602-21-030052 · form4.xml · nonDerivative · entry 1 HEGGIE THERESA · CIK 0001760020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,623 F1 · security: Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 21:08 UTC |
INGRAM ROBERT ALEXANDERDirector
|
GrantCommon Stock | 1,554 | $12.06 | $18,741.24 |
DisclosureSEC source: 0001127602-21-030043 · form4.xml · nonDerivative · entry 1 INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,932 F1 · security: Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $18,750. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 23:35 UTC |
MILANO VINCENTDirector
|
PurchaseCommon Stock | 7,500 | $12.19 | $91,425.00 |
DisclosureSEC source: 0001171843-21-008177 · ownership.xml · nonDerivative · entry 1 MILANO VINCENT · CIK 0001187159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 23:35 UTC |
Doyle AnthonyChief Financial Officer
|
PurchaseCommon Stock | 35,258 | $12.48 | $440,019.84 |
DisclosureSEC source: 0001171843-21-008176 · ownership.xml · nonDerivative · entry 1 Doyle Anthony · CIK 0001808688 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,719 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:27 UTC |
ABERCROMBIE GEORGE BDirector
|
Exercise / conversionAutomatic Stock Option Grant · Derivative | 5,000 | $0.00 Strike: $3.32 | $0.00 |
DisclosureSEC source: 0001127602-21-029440 · form4.xml · derivative · entry 3 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2022-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. F3 · derivative.exercise_date: The option vested 1/12 per month for a period of 12 months, beginning on June 23, 2012. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:27 UTC |
ABERCROMBIE GEORGE BDirector
|
SaleCommon Stock | 5,000 | $12.27 | $61,350.00 |
DisclosureSEC source: 0001127602-21-029440 · form4.xml · nonDerivative · entry 2 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $12.22 to $12.29. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:27 UTC |
ABERCROMBIE GEORGE BDirector
|
Exercise / conversionCommon Stock | 5,000 | $3.32 | $16,600.00 |
DisclosureSEC source: 0001127602-21-029440 · form4.xml · nonDerivative · entry 1 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:21 UTC |
Hutson Nancy JDirector
|
Exercise / conversionAutomatic Stock Option Grant · Derivative | 30,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001127602-21-027342 · form4.xml · derivative · entry 9 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2026-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:21 UTC |
Hutson Nancy JDirector
|
Exercise / conversionAutomatic Stock Option Grant · Derivative | 15,000 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001127602-21-027342 · form4.xml · derivative · entry 8 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:21 UTC |
Hutson Nancy JDirector
|
Exercise / conversionAutomatic Stock Option Grant · Derivative | 30,000 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0001127602-21-027342 · form4.xml · derivative · entry 7 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2027-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:21 UTC |
Hutson Nancy JDirector
|
Exercise / conversionAutomatic Stock Option Grant · Derivative | 30,000 | $0.00 Strike: $2.91 | $0.00 |
DisclosureSEC source: 0001127602-21-027342 · form4.xml · derivative · entry 6 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2029-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:21 UTC |
Hutson Nancy JDirector
|
SaleCommon Stock | 105,000 | $15.40 | $1,617,000.00 |
DisclosureSEC source: 0001127602-21-027342 · form4.xml · nonDerivative · entry 5 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,073 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.13 to $15.51. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:21 UTC |
Hutson Nancy JDirector
|
Exercise / conversionCommon Stock | 30,000 | $3.22 | $96,600.00 |
DisclosureSEC source: 0001127602-21-027342 · form4.xml · nonDerivative · entry 4 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:21 UTC |
Hutson Nancy JDirector
|
Exercise / conversionCommon Stock | 15,000 | $1.71 | $25,650.00 |
DisclosureSEC source: 0001127602-21-027342 · form4.xml · nonDerivative · entry 3 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:21 UTC |
Hutson Nancy JDirector
|
Exercise / conversionCommon Stock | 30,000 | $5.13 | $153,900.00 |
DisclosureSEC source: 0001127602-21-027342 · form4.xml · nonDerivative · entry 2 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:21 UTC |
Hutson Nancy JDirector
|
Exercise / conversionCommon Stock | 30,000 | $2.91 | $87,300.00 |
DisclosureSEC source: 0001127602-21-027342 · form4.xml · nonDerivative · entry 1 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:15 UTC |
McKee Amy EDirector
|
GrantNon-Qualified Stock Option · Derivative | 53,333 | $0.00 Strike: $15.02 | $0.00 |
DisclosureSEC source: 0001127602-21-025686 · form4.xml · derivative · entry 1 McKee Amy E · CIK 0001883764 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,333 Underlying: Common Stock · 53,333 shares Expires 2031-09-20 F1 · shares: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan. F2 · derivative.exercise_date: The option vests 1/36 per month for a period of 36 months, beginning on October 20, 2021 Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:31 UTC |
ABERCROMBIE GEORGE BDirector
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 5,000 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001127602-21-025496 · form4.xml · derivative · entry 3 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-10-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. F3 · derivative.exercise_date: The option vested 1/8 per month for a period of 8 months, beginning on October 10, 2011. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:31 UTC |
ABERCROMBIE GEORGE BDirector
|
SaleCommon Stock | 5,000 | $15.06 | $75,300.00 |
DisclosureSEC source: 0001127602-21-025496 · form4.xml · nonDerivative · entry 2 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $14.90 to $15.40. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:31 UTC |
ABERCROMBIE GEORGE BDirector
|
Exercise / conversionCommon Stock | 5,000 | $2.63 | $13,150.00 |
DisclosureSEC source: 0001127602-21-025496 · form4.xml · nonDerivative · entry 1 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:26 UTC |
LEE KENNETH B JRDirector
|
Exercise / conversionAutomatic Stock Option Grant · Derivative | 15,000 | $0.00 Strike: $3.32 | $0.00 |
DisclosureSEC source: 0001127602-21-025331 · form4.xml · derivative · entry 3 LEE KENNETH B JR · CIK 0001208570 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2022-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:26 UTC |
LEE KENNETH B JRDirector
|
SaleCommon Stock | 6,000 | $15.35 | $92,100.00 |
DisclosureSEC source: 0001127602-21-025331 · form4.xml · nonDerivative · entry 2 LEE KENNETH B JR · CIK 0001208570 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,252 F1 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.24 to $15.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:26 UTC |
LEE KENNETH B JRDirector
|
Exercise / conversionCommon Stock | 15,000 | $3.22 | $48,300.00 |
DisclosureSEC source: 0001127602-21-025331 · form4.xml · nonDerivative · entry 1 LEE KENNETH B JR · CIK 0001208570 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 20:14 UTC |
ABERCROMBIE GEORGE BDirector
|
Exercise / conversionAutomatic Stock Option Grant · Derivative | 30,000 | $0.00 Strike: $2.91 | $0.00 |
DisclosureSEC source: 0001127602-21-025252 · form4.xml · derivative · entry 7 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2029-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 20:14 UTC |
ABERCROMBIE GEORGE BDirector
|
Exercise / conversionAutomatic Stock Option Grant · Derivative | 30,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001127602-21-025252 · form4.xml · derivative · entry 6 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2026-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 20:14 UTC |
ABERCROMBIE GEORGE BDirector
|
Exercise / conversionAutomatic Stock Option Grant · Derivative | 11,000 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001127602-21-025252 · form4.xml · derivative · entry 5 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 20:14 UTC |
ABERCROMBIE GEORGE BDirector
|
SaleCommon Stock | 74,000 | $15.09 | $1,116,660.00 |
DisclosureSEC source: 0001127602-21-025252 · form4.xml · nonDerivative · entry 4 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $14.87 to $15.31. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 20:14 UTC |
ABERCROMBIE GEORGE BDirector
|
Exercise / conversionCommon Stock | 30,000 | $2.91 | $87,300.00 |
DisclosureSEC source: 0001127602-21-025252 · form4.xml · nonDerivative · entry 3 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 20:14 UTC |
ABERCROMBIE GEORGE BDirector
|
Exercise / conversionCommon Stock | 30,000 | $3.22 | $96,600.00 |
DisclosureSEC source: 0001127602-21-025252 · form4.xml · nonDerivative · entry 2 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 20:14 UTC |
ABERCROMBIE GEORGE BDirector
|
Exercise / conversionCommon Stock | 11,000 | $1.71 | $18,810.00 |
DisclosureSEC source: 0001127602-21-025252 · form4.xml · nonDerivative · entry 1 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:25 UTC |
Galson Steven KDirector
|
GrantNon-Qualified Stock Option · Derivative | 60,000 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001127602-21-024770 · form4.xml · derivative · entry 1 Galson Steven K · CIK 0001495328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2031-09-01 F1 · shares: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan. F2 · derivative.exercise_date: The option vests 1/36 per month for a period of 36 months, beginning on October 1, 2021. Read SEC document |
| September 01, 2021 Filed Dec 16, 2021 21:53 UTC |
Stonehouse Jon PDirector · President & CEO
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-031116 · form4.xml · nonDerivative · entry 4 Stonehouse Jon P · CIK 0001385496 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust Disclosed balance after: 5,000 F2 · kind: Reflects a gift of shares by the reporting person to the Caroline Stonehouse Irrevocable Trust. Read SEC document |
| September 01, 2021 Filed Dec 16, 2021 21:53 UTC |
Stonehouse Jon PDirector · President & CEO
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-031116 · form4.xml · nonDerivative · entry 3 Stonehouse Jon P · CIK 0001385496 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust Disclosed balance after: 5,000 F1 · kind: Reflects a gift of shares by the reporting person to the Samuel Stonehouse Irrevocable Trust. Read SEC document |
| September 01, 2021 Filed Dec 16, 2021 21:53 UTC |
Stonehouse Jon PDirector · President & CEO
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-031116 · form4.xml · nonDerivative · entry 2 Stonehouse Jon P · CIK 0001385496 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 778,602 F2 · kind: Reflects a gift of shares by the reporting person to the Caroline Stonehouse Irrevocable Trust. Read SEC document |
| September 01, 2021 Filed Dec 16, 2021 21:53 UTC |
Stonehouse Jon PDirector · President & CEO
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-031116 · form4.xml · nonDerivative · entry 1 Stonehouse Jon P · CIK 0001385496 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 783,602 F1 · kind: Reflects a gift of shares by the reporting person to the Samuel Stonehouse Irrevocable Trust. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 20:36 UTC |
LEVIN ALAN GDirector
|
GrantCommon Stock | 628 | $15.92 | $9,997.76 |
DisclosureSEC source: 0001127602-21-024778 · form4.xml · nonDerivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 628 F1 · security: Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 20:33 UTC |
INGRAM ROBERT ALEXANDERDirector
|
GrantCommon Stock | 1,177 | $15.92 | $18,737.84 |
DisclosureSEC source: 0001127602-21-024776 · form4.xml · nonDerivative · entry 1 INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,378 F1 · security: Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $18,750. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 20:28 UTC |
ASELAGE STEVEDirector
|
GrantCommon Stock | 314 | $15.92 | $4,998.88 |
DisclosureSEC source: 0001127602-21-024772 · form4.xml · nonDerivative · entry 1 ASELAGE STEVE · CIK 0001221599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,444 F1 · security: Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $10,000. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 20:30 UTC |
HEGGIE THERESADirector
|
GrantCommon Stock | 628 | $15.92 | $9,997.76 |
DisclosureSEC source: 0001127602-21-024774 · form4.xml · nonDerivative · entry 1 HEGGIE THERESA · CIK 0001760020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,794 F1 · security: Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 22:31 UTC |
MILANO VINCENTDirector
|
GrantNon-Qualified Stock Option · Derivative | 66,667 | $0.00 Strike: $17.25 | $0.00 |
DisclosureSEC source: 0001127602-21-022567 · form4.xml · derivative · entry 1 MILANO VINCENT · CIK 0001187159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,667 Underlying: Common Stock · 66,667 shares Expires 2031-07-26 F1 · shares: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan. F2 · derivative.exercise_date: The option vests 1/36 per month for a period of 36 months, beginning on August 26, 2021. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:39 UTC |
ABERCROMBIE GEORGE BDirector
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 5,000 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001127602-21-022226 · form4.xml · derivative · entry 3 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2021-10-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. F3 · derivative.exercise_date: The option vested 1/8 per month for a period of 8 months, beginning on October 10, 2011. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:39 UTC |
ABERCROMBIE GEORGE BDirector
|
SaleCommon Stock | 5,000 | $15.69 | $78,450.00 |
DisclosureSEC source: 0001127602-21-022226 · form4.xml · nonDerivative · entry 2 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.46 to $16.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.